IP Library Granted Patent US 11,116,220
Granted Patent B2
US 11,116,220 · App. 16/229,593 · Granted Sep 14, 2021

Antimicrobial compositions with enhanced efficacy

Inventors: Jessica Albright (Saint Paul, MN); Daniel E. Pedersen (Saint Paul, MN); Cheryl A. Littau (Saint Paul, MN); Joseph R. Wegner (Saint Paul, MN)
Assignee: Ecolab USA Inc.
A01N47/44A01N25/16A01N25/30A01N33/12A61K8/046A61K8/416A61K8/43A61Q19/10C11D1/94C11D3/48C11D1/62C11D1/75
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,116,220
App. No.
16/229,593
Granted
Sep 14, 2021
Kind
B2
Abstract

The invention relates to antimicrobial compositions and methods of making the same. In particular, to antimicrobial hand wash compositions comprising an antimicrobial active and a primary foaming agent comprising a glucosamide. Preferred compositions further comprise a secondary foaming agent and a foam structure enhancing agent.

Claims (31)

1. An antimicrobial composition comprising:

from about 0.01 wt. % to about 2 wt. % of an antimicrobial active compound comprising one or more of the following benzalkonium chloride, benzethonium chloride, chlorhexidine gluconate, and mixtures thereof, wherein the antimicrobial active compound has antimicrobial activity toward Gram positive and/or Gram negative microorganisms;

from about 0.1 wt. % to about 5 wt. % of a primary foaming agent, wherein the primary foaming agent comprises a glucosamide or a mixture of a glucosamide and a C8-C16 amine oxide derivative in a ratio of between about 90:10 and about 50:50; and

from about 65 wt. % to about 99.7 wt. % of a carrier; wherein the composition is a liquid or a gel and has a pH between about 5 and about 9;

wherein the antimicrobial composition provides an in vitro log reduction of the microorganisms of greater than or equal to 3 in about 30 seconds or less.

2. The antimicrobial composition of claim 1 , wherein the primary foaming agent is a C8-C16 glucosamide and the composition contains less than 1 wt. % amine oxide.

3. The antimicrobial composition of claim 1 , wherein the composition further comprises a secondary foaming agent in a concentration between about 0.1 wt. % and about 5 wt. %.

4. The antimicrobial composition of claim 1 , wherein the composition further comprises a chelant comprising methylglycinediacetic acid in a concentration between about 0.01 wt. % and about 1 wt. %.

5. The antimicrobial composition of claim 1 , wherein the composition further comprises a foam structure enhancing agent in a concentration between about 0.05 wt. % and about 3 wt. %.

6. The antimicrobial composition of claim 1 , wherein the composition further comprises a humectant in a concentration between about 0.05 wt. % and about 1 wt. %.

7. The antimicrobial composition of claim 1 , wherein the composition further comprises a preservative in a concentration between about 0.1 wt. % and about 2 wt. %.

8. The antimicrobial composition of claim 1 , wherein the composition further comprises an emollient in a concentration between about 0.01 wt. % and about 1 wt. %.

9. The antimicrobial composition of claim 2 , wherein the primary foaming agent comprises a C8-C16 glucosamide, and wherein the C8-C16 glucosamide comprises capryloyl/caproyl methyl glucosamide, cocoyl methyl glucamide, lauroyl/myristoyl methyl glucamide, or a mixture thereof.

10. The antimicrobial composition of claim 3 , wherein the composition further comprises a secondary foaming agent, which comprises trimethyl ammonium chloride, palmitamidopropyl trimonium chloride, a phospholipid surfactant, a phospholipid derivative surfactant, or mixtures thereof.

11. The antimicrobial composition of claim 1 , wherein the composition provides a log reduction of S. marcescens of greater than about 4 in about 30 seconds in an in vitro assay.

12. The antimicrobial composition of claim 1 , wherein the composition further comprises one or more additional functional ingredients.

13. The antimicrobial composition of claim 1 , wherein the composition is a liquid.

14. A dilutable antimicrobial composition comprising:

from about 0.3 wt. % to about 25 wt. % of an antimicrobial active compound comprising one or more of the following benzalkonium chloride, benzethonium chloride, chlorhexidine gluconate, didecyldimethylammonium chloride and mixtures thereof, wherein the antimicrobial active compound has antimicrobial activity toward Gram positive and/or Gram negative microorganisms;

from about 3 wt. % to about 50 wt. % of a primary foaming agent, wherein the primary foaming agent comprises a glucosamide or a mixture of a glucosamide and a C8-C16 amine oxide derivative in a ratio of between about 90:10 and about 50:50; and

optionally from about 0 wt. % to about 96.5 wt. % of a carrier; wherein the composition is a liquid or a gel and has a pH between about 5 and about 9;

wherein the antimicrobial composition provides an in vitro log reduction of the microorganisms of greater than or equal to 3 in about 30 seconds or less.

15. The antimicrobial composition of claim 14 , wherein the primary foaming agent is a C8-C16 glucosamide and the composition contains less than 1 wt. % amine oxide.

16. The antimicrobial composition of claim 15 , wherein the composition further comprises a secondary foaming agent in a concentration between about 1 wt. % and about 30 wt. %.

17. The antimicrobial composition of claim 16 , wherein the composition further comprises a chelant comprising methylglycinediacetic acid in a concentration between about 0.1 wt. % and about 10 wt. %.

18. The antimicrobial composition of claim 17 , wherein the composition further comprises a foam structure enhancing agent in a concentration between about 0.5 wt. % and about 35 wt. %.

19. The concentrated antimicrobial composition of claim 18 , wherein the composition is diluted at a dilution ratio between 1:5 and 1:15 to form a ready to use antimicrobial hand soap.

20. A method of preparing the antimicrobial composition of claim 1 comprising:

(a) mixing the ingredients of the composition.

21. The method of claim 20 , wherein the composition is mixed until homogenous.

22. The method of claim 21 , wherein the method further comprises diluting the composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2021
From: ALBRIGHT, JESSICA; PEDERSEN, DANIEL E.; LITTAU, CHERYL A.; WEGNER, JOSEPH R.
To: ECOLAB USA INC.
Reel/Frame 055711/0312 →
Continuity (2)
Provisional Application 62609603 · Dec 22, 2017
Related Publication 20190191704A1 · Jun 27, 2019